Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03636685 |
|---|---|
| Brief Title: | Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC |
| First Submitted : | August 13, 2018 |
| First Submitted that Met QC Criteria : | August 16, 2018 |
| First Posted : | August 17, 2018 |
| Last Update Submitted that Met QC Criteria : | August 16, 2018 |
| Last Update Posted : | August 17, 2018 |